Replimune Soars After FDA Reconsiders Denial of Skin Cancer Drug
Replimune Group, Inc. · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $9.00
+5.2% in 1h after detection
Post-detection moves
1h
+5.2%
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS